About



OUR MISSION

"Better Life through Better Medicine
contributing to improved quality of life and
public welfare by developing quality medicines."


A company that has achieved numerous ‘firsts,’ ‘bests’ and ‘very bests’.


Dedicated to pharmaceuticals since its foundation, Chong Kun Dang has overcome many challenges, while continuing to grow and contribute to the advancement of Korea’s pharmaceutical industry.

In the days when Korea imported 100% of the raw materials required for medicines from abroad, we built Korea’s largest plants for chemical synthesis and fermentation, making it possible to produce pharmaceutical ingredients locally using our own technology. From there, we had driven Korean Pharmaceutical Industry with this breakthrough on the path toward modernization.

Furthermore, we became the first Korean pharmaceutical company to export products to the US market through the obtainment of the U.S. FDA approval. Now, on its 75th anniversary, we promise to put all efforts to lead continuous change and innovation, positioning Chong Kun Dang as a global pharmaceutical company with a competitive edge in the international market.


President

Young-Joo Kim

Foundation

May 7, 1941 (Spin off on : November 5, 2013)

Business Line

Manufacturing, Sales and Marketing of Medicine

Paid in Capital

23,5 Bil. (Won)

Head Office

8, Chungjeong-ro, Seodaemun-gu, Seoul, Korea

TEL/FAX

82-2-2194-0300 / 82-2-2194-0369

Homepage

www.ckdpharm.com

  

LOCATION



·         Chong Kun Dang Seoul Headquarters
 

Address

8, Chungjeong-ro, Seodaemun-gu, Seoul, Korea

Tel

82-2-2194-0300

FAX

82-2-2194-0369

Directions

[By Subway]
Line No.2 Chungjeongro Station Exit No.1
Line No.5 Chungjeongro Station Exit No.10